tiprankstipranks
Trending News
More News >
Telesis Bio (TBIO)
OTHER OTC:TBIO
US Market

Telesis Bio (TBIO) Income Statement

Compare
138 Followers

Telesis Bio Income Statement

Last quarter (Q3 2024), Telesis Bio's total revenue was $1.57M, a decrease of -71.85% from the same quarter last year. In Q3, Telesis Bio's net income was $-6.64M. See Telesis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 27.51M$ 27.43M$ 11.04M$ 6.58M$ 4.80M
Gross Profit
$ 16.95M$ 15.60M$ 4.30M$ 3.63M$ -4.08M
Operating Expenses
$ 63.49M$ 62.08M$ 39.67M$ 19.99M$ 2.89M
Depreciation and Amortization
$ 4.10M$ 2.88M$ 1.57M$ 1.46M$ 857.00K
EBITDA
$ -40.49M$ -43.62M$ -36.00M$ -15.86M$ -5.96M
Operating Income
$ -46.54M$ -46.48M$ -35.37M$ -16.36M$ -6.98M
Other Income/Expenses
$ -1.16M$ -1.96M$ -3.57M$ -1.64M$ -1.33M
Pretax Income
$ -47.70M$ -48.45M$ -38.94M$ -18.00M$ -8.30M
Net Income
$ -47.72M$ -48.47M$ -38.96M$ -18.01M$ -8.30M
Per Share Metrics
Basic EPS
$ -1.59$ -1.65$ -1.33$ -0.62$ -0.20
Diluted EPS
$ -1.59$ -1.65$ -1.33$ -0.62$ -0.20
Weighted Average Shares Outstanding
29.93M 29.46M 29.32M 29.23M 40.76M
Weighted Average Shares Outstanding (Diluted)
29.93M 29.46M 29.32M 29.23M 40.76M
Currency in USD

Telesis Bio Earnings and Revenue History